Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response

Australian and New Zealand Journal of Public Health

Volumn 34, Issue 2, 2010, Pages 113-119

  McVernon, Jodie ^a   McCaw, James M ^a   Nolan, Terence M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antiviral agents; Disease outbreaks; H5n1 subtype; Influenza a virus; Influenza vaccines; Mathematical model

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ARTICLE; AUSTRALIA; HUMAN; INFLUENZA; PANDEMIC; POST EXPOSURE PROPHYLAXIS; PREVENTIVE HEALTH SERVICE; THEORETICAL MODEL; TIME; UTILIZATION REVIEW; VACCINATION;

ANTIVIRAL AGENTS; AUSTRALIA; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, THEORETICAL; PANDEMICS; POST-EXPOSURE PROPHYLAXIS; PREVENTIVE HEALTH SERVICES; TIME FACTORS; VACCINATION;

EID: 77952223592     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2010.00493.x     Document Type: Article

References (21)

1. Department of Health and Ageing. Australian Health Management Plan for Pandemic Influenza. Canberra (AUST): Commonwealth of Australia; 2008.
2. 2. McCaw J, Mc Vernon J. Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic. Math Biosci. 2007;209(2):336-360 (Pubitemid 47390908)
3. 3. Mossong J, Hens N, Jit M, Beutels P, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008; 5(3): e74. (Pubitemid 351471689)
4. Edmunds WJ, O'Callaghan CJ, Nokes DJ. Who mixes with whom? A method to determine the contact patterns of adults that may lead to the spread of airborne infections. Proc Biol Sci. 1997; 264(1384): 949-957
5. 5. Roberts M, Heesterbeek JA. Model-consistent estimation of the basic reproduction number from the incidence of an emerging infection. J Math Biol. 2007; 55: 803-816 (Pubitemid 47632235)
6. Fox JP, Cooney MK, Hall CE, Foy HM. Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol. 1982; 116(2): 228-242
7. 7. Halloran ME, Hayden FG, Yang Y, Longini IM Jr, et al. Antiviral effects on influenza viral transmission and pathogenicity: observations from householdbased trials. Am J Epidemiol. 2007; 165(2): 212-221 (Pubitemid 46096383)
8. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. JAntimicrob Chemother. 2003; 51(1):123-129
9. 9. Hayden FG, Belshe R, Villanueva C, Lanno R, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis. 2004; 189(3): 440-449 (Pubitemid 38210580)
10. Ferguson NM, Cummings DAT, Fraser C, Cajka J, et al. Strategies for mitigating an influenza pandemic. Nature. 2006; 442(7101): 448-452
11. Germann TC, Kadau K, Longini IM Jr, Macken CA. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci U S A. 2006; 103(15): 5935-5940
12. 12. McLean A. Vaccines and their impact on the control of disease. Br Med Bull. 1998: 545-556 (Pubitemid 28477194)
13. 13. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005; 438(7066): 355-359 (Pubitemid 41643951)
14. 14. Riley S. Large-scale spatial-transmission models of infectious disease. Science. 2007; 316(5829): 1298-1301 (Pubitemid 46871643)
15. 15. Bansal S, Grenfell BT, Meyere LA. When individaual behaviour matter: homogeneous and network models in epidemiology. J R Soc Interface. 2007; 4(16): 879-891 (Pubitemid 47523493)
16. 16. Mathews J, McCaw C, McVernon J, McBryde E, et al. A Biological Model for Influenza Transmission: Pandemic Planning Implications of Asymptomatic Infection and Immunity. PLoS ONE. 2007; 2(11): e1220. (Pubitemid 351650059)
17. McVernon J, McCaw C, Mathews J. Model answers or trivial pursuits? The role of mathematical models in influenza pandemic preparedness planning. Influenza Other Respi Viruses. 2007; 1: 43-54.
18. Lipsitch M, Cohen T, Murray M, Levin B. Antiviral resistance and the control of pandemic influenza. PLoS Med. 2007;4(1):e15.
19. McCaw J, Wood J, McCaw C, McVernon J. Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs. PLoS ONE. 2008;3(6):e2362.
20. Herlocher ML, Truscon R, Elias S, Yen HL, et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis. 2004; 190(9): 1627-1630
21. Lackenby A, Hungnes O, Dudman S, Meijer A, et al. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Euro Surveill. 2008; 13(5): 1-2.